Tandem OnabotulinumtoxinA Galcanezumab Emerging Therapeutic Headache Elimination Research Study

NCT05492695 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Stopped from financial sponsor due to inability to enroll participants.

Conditions

Migraine

Interventions

DRUG: Galcanezumab
OTHER: Placebo

Sponsor

Diamond Headache Clinic